A. Schepart

Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.

J. Bourque, Adam Castaño, J. Grodin, 2022, The American journal of cardiology.

Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk.

Kensaku Kawamoto, K. Nolen, T. Kannampallil, 2022, Future cardiology.

SCREENING OF PATIENTS AT RISK FOR WILD TYPE ATTR-CM USING A COMPUTATIONAL MACHINE LEARNING ALGORITHM

Kensaku Kawamoto, J. Biskupiak, J. Nativi-Nicolau, 2021, Journal of the American College of Cardiology.

Artificial intelligence–enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges

E. Charap, F. Ahmad, R. Bhambri, 2023, Cardiovascular digital health journal.

Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model

E. Casey, R. Sheer, Radhika Nair, 2023, Journal of managed care & specialty pharmacy.

Medicare characteristics, treatment, cost and survival in triple class exposed relapsed or refractory multiple myeloma.

P. Hlavacek, A. Petrilla, A. Schepart, 2023, Future Oncology.

Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model

E. Casey, R. Sheer, Radhika Nair, 2023, Journal of Managed Care & Specialty Pharmacy.